â??The efficacy of doxycycline in comparison to azithromycin in adult patients with non-cystic fibrosis bronchiectasis-- an open label randomised controlled trialâ??

AIIMS New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

研究概览

暂无简介。

•I.Subjects with clinical suspicion of bronchiectasis (daily signs/symptoms, such as cough, sputum production, haemoptysis or had at least one pulmonary exacerbation requiring antibiotic treatment in the past year).
•II.Subjects with confirmed diagnosis of bronchiectasis on high-resolution computed tomography.

•I.Patients who have received or receiving antibiotics prolonged (more than four weeks) macrolide therapy during the previous 1 months of screening for the study.
•II.Patients who have received or receiving corticosteroids within 1 months of screening of the study.
•III.Patients having CT findings consistent with traction bronchiectasis due to pulmonary fibrosis or cystic fibrosis at the screening.
•IV.Patients having CT findings with chronic pulmonary aspergillosis or allergic bronchopulmonary aspergillosis at the screening.
•V.Patients having a diagnosis of active pulmonary tuberculosis (microbiological or radiological evidence) at the screening.
•VI.Subjects who refuse to give their consent to take part in the study.
•VII.Female subjects who are pregnant, planning for pregnancy in next month or are lactating.

发起方

AIIMS New Delhi